Is DaShenLin Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, DaShenLin Pharmaceutical pays dividends. Last time was Wednesday 23rd of October 2024 where the investors holding the stock on Wednesday 23rd of October 2024 were paid CNY0.31 per share. Over the last 8 times between 2018 and 2024, DaShenLin Pharmaceutical has paid CNY4.42667 with an average of CNY0.55 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for DaShenLin Pharmaceutical 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was CNY28.16, you would have made a loss of CNY-13.60 per share or -48.30%
Yes, the average daily trading liquidity for DaShenLin Pharmaceutical is CNY11.95 million. You should therefore be able to get in and out of your positions relatively fast.
DaShenLin Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.38, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 3.51%, which is challenging.
We have calculated the inflation risk for DaShenLin Pharmaceutical to be low [0.5 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.